Estados financieros detallados de NRx Pharmaceuticals, Inc. (NRXP): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 32.7%, margen operativo -5.9%, margen neto -6.9%.
Al precio actual de $3.35, NRXP presenta beneficios negativos (P/E no significativo) y un ROE del 168.68%. La capitalización bursátil es de $58M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.2M |
| Coste de Ventas | 0 | $1.0M | 0 | $2000 | $2000 | $4000 | $5000 | $5000 | $505000 |
| Beneficio Bruto | 0 | -$1.0M | 0 | -$2000 | -$2000 | -$4000 | -$5000 | -$5000 | $720000 |
| I+D | 0 | 0 | 0 | $10.6M | $20.3M | $17.0M | $13.4M | $6.2M | $3.8M |
| Generales y Administrativos | 0 | $1.0M | $713187 | $11.4M | $74.9M | $27.3M | $14.2M | $13.5M | $13.1M |
| Gastos Operativos | 0 | 0 | $713187 | $22.1M | $95.2M | $44.3M | $27.6M | $19.7M | $16.9M |
| Beneficio Operativo | 0 | -$1.0M | -$713187 | -$22.1M | -$95.2M | -$44.3M | -$27.6M | -$19.7M | -$16.2M |
| EBITDA | -$105000 | $82412 | $492633 | -$51.7M | -$93.0M | -$39.8M | -$30.0M | -$24.0M | -$27.8M |
| Gastos por Intereses | 0 | 0 | 0 | $56000 | $18000 | 0 | $120000 | $1.1M | $671000 |
| Beneficio Antes de Impuestos | -$105000 | $82412 | $492633 | -$51.8M | -$93.1M | -$39.8M | -$30.1M | -$25.1M | -$28.6M |
| Impuestos | 0 | $16311 | $84206 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$105000 | $66101 | $408427 | -$51.8M | -$93.1M | -$39.8M | -$30.1M | -$25.1M | -$28.6M |
| BPA | $-0.12 | $0.07 | $0.80 | $-1.51 | $-7.44 | $-0.60 | $-3.98 | $-2.39 | $-1.34 |
| BPA Diluido | $-0.12 | $0.07 | $0.80 | $-1.51 | $-7.44 | $-0.60 | $-3.98 | $-2.39 | $-1.34 |
| Acciones en Circulación (Diluidas) | $903550 | $892496 | $508835 | $546586 | $46.9M | $65.8M | $7.6M | $10.5M | $21.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $242000 | $983000 | $1.1M | $1.1M |
| Beneficio Bruto | $104000 | $475000 | $272000 | $258000 |
| Beneficio Operativo | -$4.1M | -$4.6M | -$4.7M | -$6.5M |
| EBITDA | -$5.8M | $1.1M | -$1.0M | -$16.2M |
| Beneficio Neto | -$5.9M | $360000 | -$1.4M | -$16.5M |
| BPA | $-0.27 | $0.01 | $-0.04 | $-0.44 |
| BPA Diluido | $-0.27 | $0.01 | $-0.04 | $-0.44 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $449374 | $11079 | $6 | $1.9M | $27.6M | $20.1M | $4.6M | $1.4M | $7.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $831000 | 0 | $7000 | $6000 | 0 | $161000 |
| Inventario | 0 | 0 | 0 | $214000 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $536376 | $30193 | $69489 | $2.9M | $32.7M | $25.8M | $6.9M | $3.3M | $8.9M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $633000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.8M |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $925000 |
| Activos Totales | $69.6M | $70.8M | $32.1M | $2.9M | $32.7M | $25.8M | $7.3M | $3.7M | $13.0M |
| Cuentas por Pagar | $85671 | $551099 | 0 | $3.2M | $3.7M | $2.1M | $4.6M | $4.1M | $4.3M |
| Deuda a Corto | 0 | 0 | 0 | $249000 | $518000 | $7.7M | $9.2M | $1.6M | 0 |
| Pasivos Corrientes | $93171 | $567410 | $622441 | $46.2M | $11.9M | $15.6M | $19.0M | $21.9M | $28.6M |
| Deuda a Largo | 0 | $690000 | $2.0M | $548000 | 0 | $2.8M | 0 | $5.0M | 0 |
| Pasivos Totales | $93171 | $1.3M | $2.6M | $46.7M | $11.9M | $18.4M | $19.0M | $26.9M | $28.9M |
| Reservas | -$105033 | -$38932 | $369495 | -$90.2M | -$183.2M | -$223.0M | -$253.1M | -$278.3M | -$306.9M |
| Patrimonio Neto | $69.5M | $69.5M | $29.5M | -$43.8M | $20.8M | $7.4M | -$11.7M | -$23.2M | -$15.9M |
| Deuda Total | 0 | $690000 | $2.0M | $797000 | $518000 | $10.5M | $9.2M | $6.6M | $631000 |
| Deuda Neta | -$449374 | $678921 | $2.0M | -$1.1M | -$27.1M | -$9.5M | $4.6M | $5.1M | -$7.2M |
| Capital Circulante | $443205 | -$537217 | -$552952 | -$43.2M | $20.8M | $10.2M | -$12.2M | -$18.6M | -$19.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $7.2M | $7.8M | $6.7M | $26.7M |
| Activos Totales | $15.0M | $13.0M | $11.9M | $34.2M |
| Pasivos Totales | $40.8M | $28.9M | $25.7M | $34.3M |
| Patrimonio Neto | -$25.8M | -$15.9M | -$13.8M | -$170000 |
| Deuda Total | $10.4M | $631000 | $934000 | $1.2M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$105033 | $66101 | $408427 | -$51.8M | -$93.1M | -$39.8M | -$30.1M | -$25.1M | -$28.6M |
| Amortizaciones | 0 | 0 | 0 | $2000 | $2000 | $4000 | $5000 | $5000 | $143000 |
| Compensación en Acciones | 0 | 0 | 0 | $730000 | $7.8M | 0 | $387000 | $486000 | $228000 |
| Cambio en Capital Circulante | -$1331 | $549627 | $4662 | $3.5M | -$4.9M | $699000 | $5.2M | $5.3M | $1.4M |
| Flujo de Caja Operativo | -$135807 | -$473187 | -$792731 | -$2.3M | -$37.7M | -$39.8M | -$21.7M | -$10.6M | -$14.1M |
| Inversiones (CapEx) | 0 | 0 | $1 | -$2000 | -$7000 | 0 | -$3000 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$2.4M |
| Recompra de Acciones | $70.0M | 0 | -$40.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$135807 | -$473187 | -$792730 | -$2.3M | -$37.7M | -$39.8M | -$21.7M | -$10.6M | -$14.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.9M | -$3.7M | -$4.3M | -$8.9M |
| Inversiones (CapEx) | 0 | 0 | 0 | -$897000 |
| Flujo de Caja Libre | -$2.9M | -$3.7M | -$4.3M | -$9.8M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $68000 | $81000 | $151000 | $139000 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +163.0% | +517.9% | -12777.2% | -79.7% | +57.3% | +24.2% | +16.7% | -13.9% |
| Crecimiento BPA (anual) | | +161.8% | +979.6% | -288.8% | -392.7% | +91.9% | -563.3% | +39.9% | +43.9% |
| Cambio en Acciones (anual) | | -1.2% | -43.0% | +7.4% | +8483.8% | +40.2% | -88.5% | +38.8% | +103.5% |
| Crecimiento FCF (anual) | | -248.4% | -67.5% | -186.0% | -1563.4% | -5.4% | +45.5% | +50.9% | -32.7% |
| Margen Bruto | | | | | | | | | 58.8% |
| Margen Operativo | | | | | | | | | -1324.4% |
| Margen EBITDA | | | | | | | | | -2270.0% |
| Margen Neto | | | | | | | | | -2336.5% |
| Margen FCF | | | | | | | | | -1152.0% |
| Tasa Impositiva Efectiva | -0.0% | 19.8% | 17.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.15 | $-0.53 | $-1.56 | $-4.15 | $-0.80 | $-0.60 | $-2.86 | $-1.01 | $-0.66 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $903550 | $892496 | $508835 | $546586 | $46.9M | $65.8M | $7.6M | $10.5M | $21.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 168.68% |
| Rentabilidad sobre capital invertido | -1855.48% |
| Rentabilidad sobre activos | -68.74% |
| Margen bruto | 32.68% |
| Margen operativo | -588.24% |
| Margen neto | -691.81% |
Salud financiera
| Deuda / Patrimonio | -7.33 |
| Ratio corriente | 0.86 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -806.67 | 1376.52 | 132.50 | -161.59 | -6.42 | -18.50 | -1.16 | -0.92 | -2.02 |
| P/VC | 1.26 | 1.31 | 1.83 | -3.05 | 107.79 | 98.53 | -2.97 | -1.00 | -3.64 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 47.35 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 58.8% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -1324.4% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -2336.5% |